Relevant bibliographies by topics / Hypolipidemic therapy

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Hypolipidemic therapy'

Author: Grafiati
Published: 28 May 2022
Last updated: 30 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hypolipidemic therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hypolipidemic therapy"

1

Boeva, Boeva O. I., Kokorin V. A. Kokorin, and Khripunova A. A. Khripunova. "Combined hypolipidemic therapy for mixed atherogenic dyslipidemia: review." Therapy 1_2022 (March 21, 2022): 162–73. http://dx.doi.org/10.18565/therapy.2022.1.162-173.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Paoletti, R. "Evolution of hypolipidemic drug therapy." Atherosclerosis 144 (May 1999): 144. http://dx.doi.org/10.1016/s0021-9150(99)80556-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Benimetskaya, K. S., P. A. Atyukov, S. V. Astrakov, and Y. I. Ragino. "NEW POSSIBILITIES OF HYPOLIPIDEMIC THERAPY." Siberian Medical Review, no. 4 (2017): 65–81. http://dx.doi.org/10.20333/2500136-2017-4-65-81.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Manhas, Amit, and John A. Farmer. "Hypolipidemic therapy and cholesterol absorption." Current Atherosclerosis Reports 6, no. 2 (2004): 89–93. http://dx.doi.org/10.1007/s11883-004-0095-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dlouha, Dana, Milan Blaha, Eva Rohlova, et al. "Multiplex Protein Biomarker Profiling in Patients with Familial Hypercholesterolemia." Genes 12, no. 10 (2021): 1599. http://dx.doi.org/10.3390/genes12101599.

Full text
Abstract:
Familial hypercholesterolemia (FH), is an autosomal dominant disorder caused by mutations in the LDLR, APOB, PCSK9, and APOE genes and is characterized by high plasma levels of total and low-density lipoprotein (LDL) cholesterol. Our study aimed to analyze the influences of two different therapies on a wide spectrum of plasma protein biomarkers of cardiovascular diseases. Plasma from FH patients under hypolipidemic therapy (N = 18; men = 8, age 55.4 ± 13.1 years) and patients under combined long-term LDL apheresis/hypolipidemic therapy (N = 14; men = 7; age 58.0 ± 13.6 years) were analyzed in
APA, Harvard, Vancouver, ISO, and other styles
6

Cignarella, Andrea, Stefano Bellosta, Alberto Corsini, and Chiara Bolego. "Hypolipidemic therapy for the metabolic syndrome." Pharmacological Research 53, no. 6 (2006): 492–500. http://dx.doi.org/10.1016/j.phrs.2006.03.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kuchmin, Alexey N., Mikhail B. Nagorny, Anatoly M. Grachev, and Elena V. Smirnova. "Modern prospects of targeted hypolipidemic therapy." Bulletin of the Russian Military Medical Academy 25, no. 2 (2023): 275–88. http://dx.doi.org/10.17816/brmma321350.

Full text
Abstract:
ABSTRACT. This article analyzes new approaches to reducing atherogenic lipoproteins using lipid-lowering drugs with innovative mechanisms of action. It examines the role of different groups of lipid-lowering drugs in the overall range of modern methods for correcting lipid metabolism disorders. The significance of statins as a foundational therapy in primary and secondary prevention of cardiovascular diseases with atherosclerotic origins is emphasized. The article presents research findings on a new target in lipid-lowering therapy, namely the proprotein convertase of subtilisin/kexin type 9 (
APA, Harvard, Vancouver, ISO, and other styles
8

Sukovatykh, B. S., V. I. Vishnevsky, N. V. Bolomatov, et al. "The eff ect of standard lipid-lowering therapy and the type of stent on the course of the atherosclerotic process in the coronary arteries in patients with hereditary hypercholesterolemia and acute coronary syndrome." Clinical Medicine (Russian Journal) 102, no. 8 (2025): 641–46. https://doi.org/10.30629/0023-2149-2024-102-8-641-646.

Full text
Abstract:
Objective. Тo study the impact of standard hypolipidemic therapy and stent type on the progression of atherosclerosis in coronary arteries in patients with familial hypercholesterolemia and acute coronary syndrome. Material and methods. Analyzed treatment results of 100 patients with familial hypercholesterolemia and acute coronary syndrome, divided into two equal groups. Group 1 received bare-metal stents, while Group 2 received drug-eluting stents. All patients were prescribed standard hypolipidemic therapy to reduce restenosis risk and normalize lipid profiles. Immediate postoperative outco
APA, Harvard, Vancouver, ISO, and other styles
9

Diachuk, Dmytro D., Galina Z. Moroz та Oleksandr M. Tkalenko. "CORRECTION OF DYSLIPIDEMIA: HISTORICAL ASPECT AND CURRENT VIEW OF THE PROBLEM (REVIEW, PART IІ)". Clinical and Preventive Medicine, № 4 (30 квітня 2025): 134–44. https://doi.org/10.31612/2616-4868.4.2025.17.

Full text
Abstract:
Aim. To summarize scientific publications, clinical guidelines (CG) regarding the development of standardized approaches to the correction of dyslipidemia and the introduction of new hypolipidemic drugs at the current stage. Materials and methods. The analysis and generalization of scientific articles, clinical guidelines on the introduction of standardized approaches to the correction of dyslipidemia at the current stage and the use of new hypolipidemic drugs for the prevention and treatment of cardiovascular diseases (CVD) were carried out. Methods were used: systematic approach, biblioseman
APA, Harvard, Vancouver, ISO, and other styles
10

Singh, Roy Sukbir, and Hendrika A. Silitonga. "Hypolipidemic Effects Of Aloe Vera (Aloe Vera L.)." International Journal of Biomedical Herbal Medicine 1, no. 1 (2021): 15–28. http://dx.doi.org/10.46880/ijbhm.v1i1.732.

Full text
Abstract:
Background: Chronic hyperlipidemia is a trigger factor for serious diseases, one of which is atherosclerosis. Lipid profile disorders in the form of increased total cholesterol, LDL and decreased HDL levels are believed to be one of the major triggering factors for cardiovascular disease. One of the treatments for hyperlipidemia in addition to using conventional therapy can also be with traditional treatments such as aloe vera (Aloe Vera L). The content of glucomannan in aloe vera is believed to act as a hypolipidemic agent. Method: This paper uses a literature study or literature review of re
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Hypolipidemic therapy"

1

Кириченко, Наталія Миколаївна, Наталия Николаевна Кириченко, Nataliia Mykolaivna Kyrychenko, M. V. Prokopishek, and F. Aldusari. "Hypolipidemic therapy in with metabolic syndrome and nonalcoholic fatty liver disease." Thesis, Сумський державний університет, 2014. http://essuir.sumdu.edu.ua/handle/123456789/35753.

Full text
Abstract:
Metabolic syndrome (MS) and non-alcoholic fatty liver disease (NAFLD) induce significant increase of triglycerides (TG), total cholesterol (TC) and low density lipoproteins (LDL), which is associated with the risk of cardiovascular disease and requires high doses of statins and possibly in combination with fibrates. This combination of drugs can result in a pronounced hepatotoxicity. Therefore, ursodeoxycholic acid (UDCA) was included as a hepatoprotector into the complex treatment of these patients. When you are citing the document, use the following link http://essuir.sumdu.edu.ua/handle/123
APA, Harvard, Vancouver, ISO, and other styles
2

Мелеховець, Оксана Костянтинівна, Оксана Константиновна Мелеховец, Oksana Kostiantynivna Melekhovets, В. В. Котков, О. Б. Вецко та Д. О. Лук`яненко. "Ефективність гіполіпідемічної терапії в профілактиці діабетичних макроангіопатій". Thesis, Видавництво СумДУ, 2010. http://essuir.sumdu.edu.ua/handle/123456789/5333.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Мелеховець, Оксана Костянтинівна, Оксана Константиновна Мелеховец, Oksana Kostiantynivna Melekhovets та ін. "Оцінка ефективності гіполіпідемічної терапії на ранніх стадіях розвитку цукрового діабету 2 типу". Thesis, Видавництво СумДУ, 2008. http://essuir.sumdu.edu.ua/handle/123456789/6497.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

"The hypolipidemic and antiatherosclerotic effect of fungal polysaccharides." 2000. http://library.cuhk.edu.hk/record=b5895813.

Full text
Abstract:
Koon Chi Man.<br>Thesis (M.Phil.)--Chinese University of Hong Kong, 2000.<br>Includes bibliographical references (leaves 158-174).<br>Abstracts in English and Chinese.<br>Acknowledgment --- p.i<br>Abbreviations --- p.ii<br>Abstract --- p.v<br>Chinese Abstract --- p.viii<br>Table of Content --- p.x<br>Chapter Chapter one: --- Introduction --- p.1<br>Chapter 1.1 --- Introduction --- p.1<br>Chapter 1.2 --- Classification of Plant Polysaccharides --- p.2<br>Chapter 1.2.1 --- Definition of Dietary Fiber --- p.3<br>Chapter 1.2.2 --- Types of Soluble Dietary Fiber --- p.3<br>Chapter 1.3 ---
APA, Harvard, Vancouver, ISO, and other styles
5

"The antioxidative and hypolipidemic activities of hawthorn fruit." 2001. http://library.cuhk.edu.hk/record=b6073385.

Full text
Abstract:
by Zhang Ze Sheng.<br>"October 2001."<br>Thesis (Ph.D.)--Chinese University of Hong Kong, 2001.<br>Includes bibliographical references (p. 157-174).<br>Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web.<br>Mode of access: World Wide Web.<br>Abstracts in English and Chinese.
APA, Harvard, Vancouver, ISO, and other styles
6

"Hypolipidemic, antioxidative and vascular effects of soy leaves (Glycine max L. Merr.)." 2001. http://library.cuhk.edu.hk/record=b5890593.

Full text
Abstract:
Ho Hing Man.<br>Thesis (M.Phil.)--Chinese University of Hong Kong, 2001.<br>Includes bibliographical references (leaves 140-156).<br>Abstracts in English and Chinese.<br>Chapter Chapter 1 --- General introduction<br>Chapter 1.1 --- History of soybean --- p.1<br>Chapter 1.2 --- Health benefits of soybean --- p.2<br>Chapter 1.3 --- Introduction to flavonoids --- p.2<br>Chapter 1.4 --- Bioavailability of flavonoids from foods --- p.3<br>Chapter 1.5 --- Pharmacological effects of flavonoids and their glycosides --- p.4<br>Chapter 1.5.1 --- Anticarcinogenic activity --- p.4<br>Chapter 1.5.2 -
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Hypolipidemic therapy"

1

Godefridus, Bruschke Albert Vincent, ed. Lipid-lowering therapy and progression of coronary atherosclerosis. Kluwer Academic Publishers, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Morrell, Jonathan, Mike Kirby, and James Shepherd. Lipid Disorders (Bestmedicine). CSF Medical Communications Ltd, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wellens, Hein J. J., Johan H. C. Reiber, A. V. Bruschke, and K. J. Lie. Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis. Springer London, Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Reiber, Johan H. C. Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis. Island Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Stone, Neil J. The Management of Lipids in Clinical Practice. Professional Communications, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Durrington, Paul N. Hyperlipidemia (Fast Facts). 3rd ed. Not Avail, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Stone, Neil J. Management of Lipids In Clinical Practice. Harcourt, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Betteridge, D. J., and J. M. Morrell. Clinicians' Guide to Lipids and Coronary Heart Disease (Clinicians' Guides). 2nd ed. A Hodder Arnold Publication, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Hypolipidemic therapy"

1

Morganroth, Joel. "What are the Recommendations to the Medical Community to Institute Hypolipidemic Therapy?" In Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-1605-3_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Anderson, Jeffrey L. "New Agents and New Insights for Thrombolytic Therapy in Acute Myocardial Infarction: Focus on Anistreplase, Urokinase, and Prourokinase." In Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-1605-3_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Loktionov, Alexandre. "Hypolipidemic Therapy." In Nutrient-Drug Interactions. CRC Press, 2006. http://dx.doi.org/10.1201/9781420019131.ch2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

"Hypolipidemic Therapy: Drugs, Diet, and Interactive Effects." In Nutrient-Drug Interactions. CRC Press, 2006. http://dx.doi.org/10.1201/9781420019131-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Akhtar, Shahrukh, Zukhruf Nadeem, and Shehla Perveen. "Ethnobotanical, Pharmacological, and Therapeutic Significance of Dill Plants and Their Role in the Biogenic Synthesis of Crucial Chemical Substances." In Advances in Bioinformatics and Biomedical Engineering. IGI Global, 2024. http://dx.doi.org/10.4018/979-8-3693-6105-4.ch007.

Full text
Abstract:
Dill, also known as Anethum graveolens, is a botanical species with an annual life cycle and a branching structure. It is a significant part of Ayurvedic medicine and is used as a spice, flavor enhancer, and essential oil supplier. Dill seeds have carminative, stomachic, and diuretic properties. The volatile components of dill seeds and plants are diverse, with carvone being the main odorant. Other substances found in seeds include steroids, phenolic acids, flavonoids, and coumarins. Dill is used in traditional herbal therapy to treat various ailments, including respiratory issues, stomach dis
APA, Harvard, Vancouver, ISO, and other styles
6

Touiss, Ilham, Mahmoud A. Elfaky, Mohamed L. Ashour, and Hicham Harnafi. "Insights into the Recent Application of Rosmarinic Acid in Therapy." In New Findings from Natural Substances. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/9789815051421122010006.

Full text
Abstract:
Herbs are key players in many traditional health care systems that have been used in medical practices since ancient times. The beneficial therapeutic effects of these medicinal plants resulted from the combinations of their secondary metabolite. Nowadays, the use of natural compounds is increasing around the world due to their relatively mild potentials and low side effects, Polyphenols are the most important compounds that exhibit diverse activities. Among these polyphenols, rosmarinic acid (RA) attracted much attention from the researchers since it was isolated as the main compound in many
APA, Harvard, Vancouver, ISO, and other styles
7

Parcha, Versha, Pankaj Bhandri, Ajay Rana, and Shivani Kashyap. "FROM TRADITIONAL KNOWLEDGE TO MODERN MEDICINE: CYPERUS SCARIOSUS AND ITS MULTIFACETED PHARMACOLOGICAL PROPERTIE." In Futuristic Trends in Chemical Material Sciences & Nano Technology Volume 3 Book 2. Iterative International Publishers, Selfypage Developers Pvt Ltd, 2024. http://dx.doi.org/10.58532/v3becm2ch20.

Full text
Abstract:
Due to their vast store of organic natural components, medicinal and aromatic plants like Cyperus scariosus play a significant role in both traditional and modern medicine. In poor nations where traditional medical practises are still relevant, these herbs are highly appreciated. The negligible side effects of medicinal plants, in contrast to manufactured drugs, make them helpful for treating a variety of illnesses. The Cyperaceae family includes Cyperus scariosus, sometimes referred to as Nut grass or Nagarmotha, which is well renowned for its medicinal properties.An vital component in Ayurve
APA, Harvard, Vancouver, ISO, and other styles
8

Kumar Sahu, Pratap, and Prashant Tiwari. "Impact of Shodhana on Semecarpus anacardium Nuts." In Alternative Medicine - Update. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.94189.

Full text
Abstract:
Semecarpus anacardium is classified in Ayurveda under the category of toxic plants. However, this toxic plant is reported to possess anti-inflammatory activity, anti-arthritic effect, antioxidant activity, antimicrobial activity, anti- carcinogenic activity, hypoglycemic activity, cardioprotective, hepatoprotective, neuroprotective, and hypolipidemic activity etc. All these activities are attributed to its various constituents like phenolic compounds, flavonoids, carbohydrates, alkaloids, steroids, etc. In Ayurveda, a series of pharmaceutical procedures which converts a poisonous drug into a s
APA, Harvard, Vancouver, ISO, and other styles
9

Gupta, Palak, Neetika Naudiyal, Pratima Raypa, and Vandana A. Kumar. "Pharmacognostic Profile of a Potent Medicinal Herb: Nardostachys Jatamansi." In The Chemistry inside Spices & Herbs: Research and Development. BENTHAM SCIENCE PUBLISHERS, 2024. http://dx.doi.org/10.2174/9789815196832124040007.

Full text
Abstract:
Nardostachys jatamansi DC, a small, erect, perennial, rhizomatous herb growing on steep, moist, rocky, undisturbed grassy slopes, is a popular species of aromatic and medicinal plant. The Sanskrit word “Jata,” which denotes a matted and uncombed lock of hair, is similar to its rhizome, hence the name “ Jatamansi.” The plant is found between 3000 and 5200 m above sea level in the alpine Himalayas, which include parts of Uttarakhand, Himachal Pradesh, Arunachal Pradesh, and Sikkim in India, as well as numerous regions of Nepal, Tibet, China, and Bhutan. N. jatamansi has been used in ayurveda, et
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Hypolipidemic therapy"

1

Abduldayeva, Aigul, and Ainagul Kazbekova. "Dynamics of lipid metabolism in the combined therapy of antihypertensive and hypolipidemic drugs in patients with metabolic syndrome." In Diabetes Kongress 2023 - 57. Jahrestagung der DDG. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0043-1767897.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Hypolipidemic therapy' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography